Linkage to Care - Part I

HIV Clinical Trial

Official title:

HIV-Related Care Engagement: Linkage to Care and Care-Seeking for HIV-Infected Adolescents, Phase I

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00703040
• Other study ID #: ATN 066a
• Status: Completed
• Phase: N/A
• First received: June 20, 2008
• Last updated: February 27, 2017
• Start date: March 2008
• Est. completion date: March 2010

Study information

• Verified date: February 2016
• Source: University of North Carolina, Chapel Hill
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This first phase of a two-phase study involves three components:

1. Review of existing linkage-to-care protocols and sources of referrals for care;

2. Semi-structured telephone or face-to-face interviews with a minimum of two personnel per site who are associated with linkage to medical care. (Preference will be given to personnel with direct experience in linkage to care); and

3. Structured observations of referral sessions.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 35
• Est. completion date: March 2010
• Est. primary completion date: March 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Component 1: Documents identified by clinical site personnel as pertaining to post-test counseling, linkage to care, or standard operating procedures addressing post-test counseling and linkage to care.

• Component 2: Persons employed by one of the AMTUs or an identified linkage-to-care partner and work as clinical staff or a case-manager or is a person familiar to linkage to care; or persons involved in posttest counseling and linkage-to-care processes. Clinical staff and case managers are chosen based on direct experience in the assistance of HIV seropositive youth obtaining medical care. This definition includes, but is not limited to, physicians, nurses, psychologists, social workers, and case managers (who may have diverse professional backgrounds).

• Component 3: All AMTU sites will be included.

Exclusion Criteria:

• Component 1: No a priori exclusions.

• Component 2: No a priori exclusions.

• Component 3: No a priori exclusions.

Related Conditions & MeSH terms

• HIV

Locations

Country	Name	City	State
United States	Montefiore Medical Center	Bronx	New York
United States	Childrens Diagnostic&Treatment Center	Fort Lauderdale	Florida
United States	Mount Sinai Medical Center	Manhattan	New York
United States	St. Jude Childrens Research Hospital	Memphis	Tennessee
United States	University of Miami School of Medicine	Miami	Florida
United States	Children's Hospital of Philadelphia	Philadelphia	Pennsylvania
United States	Children's National Medical Center	Washington	District of Columbia

Sponsors (3)

Lead Sponsor	Collaborator
University of North Carolina, Chapel Hill	National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Describe and evaluate community screening standards and practices.		1 year
Primary	Describe and evaluate the relationships of screening venues with care-providing venues.		1 year
Primary	Describe and evaluate referral and intake protocols.		1 year
Primary	Describe and evaluate care adherence support (including support from both clinical and non-clinical sources).		1 year

External Links

•   Adolescent Trials Network website